0001127602-22-013640.txt : 20220506 0001127602-22-013640.hdr.sgml : 20220506 20220506160609 ACCESSION NUMBER: 0001127602-22-013640 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220504 FILED AS OF DATE: 20220506 DATE AS OF CHANGE: 20220506 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Andres Juan CENTRAL INDEX KEY: 0001760670 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38753 FILM NUMBER: 22901040 MAIL ADDRESS: STREET 1: C/O MODERNA, INC. STREET 2: 200 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Moderna, Inc. CENTRAL INDEX KEY: 0001682852 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 813467528 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6177146500 MAIL ADDRESS: STREET 1: 200 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Moderna Therapeutics, Inc. DATE OF NAME CHANGE: 20160822 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2022-05-04 0001682852 Moderna, Inc. MRNA 0001760670 Andres Juan C/O MODERNA, INC. 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 1 See remarks Common Stock 2022-05-04 4 M 0 2000 14.22 A 11069 D Common Stock 2022-05-04 4 S 0 2000 153.23 D 9069 D Stock Option (Right to Buy) 14.22 2022-05-04 4 M 0 2000 0 D 2028-02-28 Common Stock 2000 629 D The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 19, 2021. This option is fully vested and exercisable. Chief Technical Operations and Quality Officer /s/ Brian Sandstrom, as Attorney-in-Fact 2022-05-06